Synergistic co-delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatment
- 1 November 2014
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 88 (3) , 1086-1093
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (51222307, 51233004, 51321062, 51390484)
- Jilin Province Science and Technology Development Program
This publication has 36 references indexed in Scilit:
- Rational Design of Polyion Complex Nanoparticles to Overcome Cisplatin Resistance in Cancer TherapyAdvanced Materials, 2013
- Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancerJournal of Controlled Release, 2013
- Synergistic gene and drug tumor therapy using a chimeric peptideBiomaterials, 2013
- Drug and plasmid DNA co-delivery nanocarriers based on abctype polypeptide hybrid miktoarm star copolymersChinese Journal of Polymer Science, 2013
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay MethodCancer Research, 2010
- Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination StudiesPharmacological Reviews, 2006
- Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trialsBMJ, 2003
- Review of randomised controlled trials of traditional Chinese medicineBMJ, 1999
- Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trialThe Lancet, 1999
- Statistical analysis of drug combinations for synergismPain, 1992